Skip to main content

Advertisement

SpringerLink
Log in

The Importance of Considering Sex Differences in Translational Stroke Research

  • SI: Challenges and Controversies in Translational Stroke Research
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

Abstract

Stroke is the second leading cause of death worldwide, and differences between men and women have been documented in incidence, prevalence, and outcome. Here, we reviewed the literature on sex differences in stroke severity, mortality, functional outcome, and response to therapies after ischemic stroke. Many of the sex differences in stroke severity and mortality are explained by differences in baseline demographics such as older age in women. However, women account for more stroke deaths, consistently suffer from worse stroke outcomes, and are more often institutionalized and permanently disabled than men. These sex differences in functional outcome are equalized after treatment with tissue plasminogen activator (tPA) and women may benefit more from treatment than men. However, this may depend on race, as African-American women have less of a response to tPA than other groups. Regarding endovascular treatments, the few existing studies that have investigated sex differences in stroke outcome point to equal benefit in both sexes; however, many clinical trials are relatively underpowered to detect sex differences. Further, we considered sex-specific effects in animal models of stroke and present recommendations for the performance of stroke studies in female animals. The male-biased use of research animals is distinguished from the clinical situation where there is a disproportionate and growing female stroke population. Stroke in women is greatly understudied, and including both sexes is especially important in both preclinical and clinical studies that evaluate potential stroke therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245–54.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322.

    Article  PubMed  Google Scholar 

  3. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40:1082–90.

    Article  PubMed  Google Scholar 

  4. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915–26.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dehlendorff C, Andersen KK, Olsen TS. Sex disparities in stroke: women have more severe strokes but better survival than men. J Am Heart Assoc. 2015;4.

  6. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke. 2003;34:1114–9.

    Article  PubMed  Google Scholar 

  7. Reeves MJ, Fonarow GC, Zhao X, Smith EE, Schwamm LH, Get With The Guidelines-Stroke Steering C, et al. Quality of care in women with ischemic stroke in the GWTG program. Stroke. 2009;40:1127–33.

  8. Ullberg T, Zia E, Petersson J, Norrving B. Changes in functional outcome over the first year after stroke: an observational study from the Swedish stroke register. Stroke. 2015;46:389–94.

    Article  PubMed  Google Scholar 

  9. Barker-Collo S, Bennett DA, Krishnamurthi RV, Parmar P, Feigin VL, Naghavi M, et al. Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the Global Burden of Disease Study 2013. Neuroepidemiology. 2015;45:203–14.

    Article  PubMed  Google Scholar 

  10. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296:2939–46.

    Article  CAS  PubMed  Google Scholar 

  11. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426–31.

    Article  PubMed  Google Scholar 

  12. Lofmark U, Hammarstrom A. Evidence for age-dependent education-related differences in men and women with first-ever stroke. Results from a community-based incidence study in northern Sweden. Neuroepidemiology. 2007;28:135–41.

    Article  PubMed  Google Scholar 

  13. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham Heart Study. Stroke. 2009;40:1032–7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366:1773–83.

    Article  CAS  PubMed  Google Scholar 

  15. Vangen-Lonne AM, Wilsgaard T, Johnsen SH, Carlsson M, Mathiesen EB. Time trends in incidence and case fatality of ischemic stroke: the Tromsø study 1977-2010. Stroke. 2015;46:1173–9.

    Article  PubMed  Google Scholar 

  16. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham Heart Study. Stroke. 2009;40:1044–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.

    Article  CAS  PubMed  Google Scholar 

  18. Olsen TS, Andersen ZJ, Andersen KK. Explaining poorer stroke outcomes in women: women surviving 3 months have more severe strokes than men despite a lower 3-month case fatality. Gend Med. 2012;9:147–53.

    Article  PubMed  Google Scholar 

  19. Gall SL, Donnan G, Dewey HM, Macdonell R, Sturm J, Gilligan A, et al. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology. 2010;74:975–81.

    Article  CAS  PubMed  Google Scholar 

  20. Li B, Wang T, Lou Y, Guo X, Gu H, Zhu Y, et al. Sex differences in outcomes and associated risk factors after acute ischemic stroke in elderly patients: a prospective follow-up study. J Stroke Cerebrovasc Dis. 2015.

  21. Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke. 2008;39:1090–5.

    Article  PubMed  Google Scholar 

  22. Kapral MK, Degani N, Hall R, Fang J, Saposnik G, Richards J, et al. Gender differences in stroke care and outcomes in Ontario. Womens Health Issues. 2011;21:171–6.

    Article  PubMed  Google Scholar 

  23. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, et al. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke. 2005;36:809–14.

    Article  PubMed  Google Scholar 

  24. Madsen TE, Choo EK, Seigel TA, Palms D, Silver B. Lack of gender disparities in emergency department triage of acute stroke patients. West J Emerg Med. 2015;16:203–9.

    Article  PubMed  Google Scholar 

  25. Barrett KM, Brott TG, Brown Jr RD, Frankel MR, Worrall BB, Silliman SL, et al. Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis. 2007;16:34–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Irie F, Kamouchi M, Hata J, Matsuo R, Wakisaka Y, Kuroda J, et al. Sex differences in short-term outcomes after acute ischemic stroke: the Fukuoka Stroke Registry. Stroke. 2015;46:471–6.

    Article  PubMed  Google Scholar 

  27. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke. 2003;34:1581–5.

    Article  PubMed  Google Scholar 

  28. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, et al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34:1970–5.

    Article  PubMed  Google Scholar 

  29. Lisabeth LD, Reeves MJ, Baek J, Skolarus LE, Brown DL, Zahuranec DB, et al. Factors influencing sex differences in poststroke functional outcome. Stroke. 2015;46:860–3.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gargano JW, Wehner S, Reeves M. Sex differences in acute stroke care in a statewide stroke registry. Stroke. 2008;39:24–9.

    Article  PubMed  Google Scholar 

  31. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003;34:122–6.

    Article  PubMed  Google Scholar 

  32. Weimar C, Ziegler A, Konig IR, Diener HC. Predicting functional outcome and survival after acute ischemic stroke. J Neurol. 2002;249:888–95.

    Article  PubMed  Google Scholar 

  33. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000;31:1833–7.

    Article  CAS  PubMed  Google Scholar 

  34. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A, International Stroke Trial Collaborative G. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the International Stroke Trial. Neuroepidemiology. 2005;24:123–8.

    Article  PubMed  Google Scholar 

  35. Gargano JW, Reeves MJ, Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry. Stroke. 2007;38:2541–8.

    Article  PubMed  Google Scholar 

  36. Lai SM, Duncan PW, Dew P, Keighley J. Sex differences in stroke recovery. Prev Chronic Dis. 2005;2:A13.

    PubMed  Google Scholar 

  37. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006;295:306–13.

    Article  CAS  PubMed  Google Scholar 

  38. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36:62–5.

    Article  CAS  PubMed  Google Scholar 

  39. Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, et al. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke. 2006;37:2322–5.

    Article  CAS  PubMed  Google Scholar 

  40. Al-hussain F, Hussain MS, Molina C, Uchino K, Shuaib A, Demchuk AM, et al. Does the sex of acute stroke patients influence the effectiveness of rt-PA? BMC Neurol. 2014;14:60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Forster A, Gass A, Kern R, Wolf ME, Ottomeyer C, Zohsel K, et al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40:2428–32.

    Article  PubMed  Google Scholar 

  42. Hametner C, Kellert L, Ringleb PA. Impact of sex in stroke thrombolysis: a coarsened exact matching study. BMC Neurol. 2015;15:10.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jovanovic DR, Beslac-Bumbasirevic L, Budimkic M, Pekmezovic T, Zivkovic M, Kostic VS, et al. Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian Experience with Thrombolysis in Ischemic Stroke (SETIS) study. Clin Neurol Neurosurg. 2009;111:729–32.

    Article  CAS  PubMed  Google Scholar 

  44. Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: of CASES, controls, and treatment-effect modification. Neurology. 2008;71:1080–3.

    Article  CAS  PubMed  Google Scholar 

  45. Lorenzano S, Ahmed N, Falcou A, Mikulik R, Tatlisumak T, Roffe C, et al. Does sex influence the response to intravenous thrombolysis in ischemic stroke?: answers from safe implementation of treatments in Stroke-International Stroke Thrombolysis Register. Stroke. 2013;44:3401–6.

    Article  CAS  PubMed  Google Scholar 

  46. Meseguer E, Mazighi M, Labreuche J, Arnaiz C, Cabrejo L, Slaoui T, et al. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke. 2009;40:2104–10.

    Article  CAS  PubMed  Google Scholar 

  47. Elkind MS, Prabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC, et al. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology. 2007;68:842–8.

    Article  CAS  PubMed  Google Scholar 

  48. Roy-O’Reilly M, McCullough LD. Sex differences in stroke: the contribution of coagulation. Exp Neurol. 2014;259:16–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Niessen F, Hilger T, Hoehn M, Hossmann KA. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke. 2003;34:2019–24.

    Article  CAS  PubMed  Google Scholar 

  50. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005;36:1447–51.

    Article  PubMed  Google Scholar 

  51. Arnold M, Kappeler L, Nedeltchev K, Brekenfeld C, Fischer U, Keserue B, et al. Recanalization and outcome after intra-arterial thrombolysis in middle cerebral artery and internal carotid artery occlusion: does sex matter? Stroke. 2007;38:1281–5.

    Article  PubMed  Google Scholar 

  52. Shah SH, Liebeskind DS, Saver JL, Starkman S, Vinuela F, Duckwiler G, et al. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke. Neurology. 2006;66:1745–6.

    Article  CAS  PubMed  Google Scholar 

  53. Cho TH, Nighoghossian N, Mikkelsen IK, Derex L, Hermier M, Pedraza S, et al. Reperfusion within 6 hours outperforms recanalization in predicting penumbra salvage, lesion growth, final infarct, and clinical outcome. Stroke. 2015;46:1582–9.

    Article  PubMed  Google Scholar 

  54. Soares BP, Tong E, Hom J, Cheng SC, Bredno J, Boussel L, et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke. 2010;41:e34–40.

    Article  PubMed  Google Scholar 

  55. Llull L, Laredo C, Renu A, Perez B, Vila E, Obach V, et al. Uric acid therapy improves clinical outcome in women with acute ischemic stroke. Stroke. 2015.

  56. Mandava P, Murthy SB, Munoz M, McGuire D, Simon RP, Alexandrov AV, et al. Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex. Stroke. 2013;44:1525–31.

    Article  CAS  PubMed  Google Scholar 

  57. Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL. Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans. J Am Coll Cardiol. 2004;44:165–7.

    Article  CAS  PubMed  Google Scholar 

  58. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119–25.

  59. Ingall TJ, O’Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke. 2004;35:2418–24.

    Article  CAS  PubMed  Google Scholar 

  60. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.

    Article  PubMed  CAS  Google Scholar 

  61. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.

    Article  CAS  PubMed  Google Scholar 

  62. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.

    Article  CAS  PubMed  Google Scholar 

  63. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.

    Article  CAS  PubMed  Google Scholar 

  64. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.

    Article  CAS  PubMed  Google Scholar 

  65. Lutsep HL, Hill MD. Effects of sex on mechanical embolectomy outcome. J Stroke Cerebrovasc Dis. 2012;21:240–2.

    Article  PubMed  Google Scholar 

  66. Lowhagen Henden P, Rentzos A, Karlsson JE, Rosengren L, Sundeman H, Reinsfelt B, et al. Hypotension during endovascular treatment of ischemic stroke is a risk factor for poor neurological outcome. Stroke. 2015.

  67. Hall ED, Pazara KE, Linseman KL. Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab. 1991;11:292–8.

    Article  CAS  PubMed  Google Scholar 

  68. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke. 1998;29:159–65. discussion 66.

    Article  CAS  PubMed  Google Scholar 

  69. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, et al. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab. 1998;18:1253–8.

    Article  CAS  PubMed  Google Scholar 

  70. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, et al. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg. 1997;87:724–30.

    Article  CAS  PubMed  Google Scholar 

  71. Manwani B, Liu F, Scranton V, Hammond MD, Sansing LH, McCullough LD. Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol. 2013;249:120–31.

    Article  PubMed  Google Scholar 

  72. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke. 2000;31:161–8.

    Article  CAS  PubMed  Google Scholar 

  73. Toung TJ, Traystman RJ, Hurn PD. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke. 1998;29:1666–70.

    Article  CAS  PubMed  Google Scholar 

  74. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci U S A. 2007;104:6013–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Cai M, Ma YL, Qin P, Li Y, Zhang LX, Nie H, et al. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice. Neurosci Lett. 2014;558:115–9.

    Article  CAS  PubMed  Google Scholar 

  76. Liu F, Benashski SE, Xu Y, Siegel M, McCullough LD. Effects of chronic and acute oestrogen replacement therapy in aged animals after experimental stroke. J Neuroendocrinol. 2012;24:319–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Yang SH, Shi J, Day AL, Simpkins JW. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke. 2000;31:745–9. discussion 9–50.

    Article  CAS  PubMed  Google Scholar 

  78. McCullough LD, Alkayed NJ, Traystman RJ, Williams MJ, Hurn PD. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke. 2001;32:796–802.

    Article  CAS  PubMed  Google Scholar 

  79. Carswell HV, Dominiczak AF, Macrae IM. Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2000;278:H290–4.

    CAS  PubMed  Google Scholar 

  80. Manwani B, Bentivegna K, Benashski SE, Venna VR, Xu Y, Arnold AP, et al. Sex differences in ischemic stroke sensitivity are influenced by gonadal hormones, not by sex chromosome complement. J Cereb Blood Flow Metab. 2015;35:221–9.

    Article  CAS  PubMed  Google Scholar 

  81. Arnold AP. Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J Neuroendocrinol. 2009;21:377–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Ritzel RM, Capozzi LA, McCullough LD. Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav. 2013;63:238–53.

    Article  CAS  PubMed  Google Scholar 

  83. Strom JO, Theodorsson A, Theodorsson E. Mechanisms of estrogens’ dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia. Int J Mol Sci. 2011;12:1533–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Carswell HV, Bingham D, Wallace K, Nilsen M, Graham DI, Dominiczak AF, et al. Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats. J Cereb Blood Flow Metab. 2004;24:298–304.

    Article  CAS  PubMed  Google Scholar 

  85. Gordon KB, Macrae IM, Carswell HV. Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res. 2005;1036:155–62.

    Article  CAS  PubMed  Google Scholar 

  86. Selvamani A, Sohrabji F. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging. 2010;31:1618–28.

    Article  CAS  PubMed  Google Scholar 

  87. Carswell HV, Macrae IM, Farr TD. Complexities of oestrogen in stroke. Clin Sci (Lond). 2010;118:375–89.

    Article  CAS  Google Scholar 

  88. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605–13.

    Article  CAS  PubMed  Google Scholar 

  89. Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, et al. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation. 2001;103:638–42.

    Article  CAS  PubMed  Google Scholar 

  90. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial. Jama. 2003;289:2673–84.

    Article  CAS  PubMed  Google Scholar 

  91. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243–9.

    Article  CAS  PubMed  Google Scholar 

  92. Rocca WA, Grossardt BR, Miller VM, Shuster LT, Brown RD, Jr. Premature menopause or early menopause and risk of ischemic stroke. Menopause. 2012;19:272–7.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005;8:3–12.

    Article  CAS  PubMed  Google Scholar 

  94. Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014;161:249–60.

    Article  PubMed  Google Scholar 

  95. Li J, Siegel M, Yuan M, Zeng Z, Finnucan L, Persky R, et al. Estrogen enhances neurogenesis and behavioral recovery after stroke. J Cereb Blood Flow Metab. 2011;31:413–25.

    Article  CAS  PubMed  Google Scholar 

  96. Meyer DM, Eastwood JA, Compton MP, Gylys K, Zivin JA. rLOAD: does sex mediate the effect of acute antiplatelet loading on stroke outcome. Biol Sex Differ. 2014;5:9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. Murphy SJ, Kirsch JR, Zhang W, Grafe MR, West GA, del Zoppo GJ, et al. Can gender differences be evaluated in a rhesus macaque (Macaca mulatta) model of focal cerebral ischemia? Comp Med. 2008;58:588–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Herson PS, Koerner IP, Hurn PD. Sex, sex steroids, and brain injury. Semin Reprod Med. 2009;27:229–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Wong R, Bath PM, Kendall D, Gibson CL. Progesterone and cerebral ischaemia: the relevance of ageing. J Neuroendocrinol. 2013;25:1088–94.

    Article  CAS  PubMed  Google Scholar 

  100. Gibson CL, Coomber B, Murphy SP. Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain. 2011;134:2125–33.

    Article  PubMed  Google Scholar 

  101. Murphy SJ, Littleton-Kearney MT, Hurn PD. Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. J Cereb Blood Flow Metab. 2002;22:1181–8.

    Article  CAS  PubMed  Google Scholar 

  102. Gibson CL, Murphy SP. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab. 2004;24:805–13.

    Article  CAS  PubMed  Google Scholar 

  103. Jiang N, Chopp M, Stein D, Feit H. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 1996;735:101–7.

    Article  CAS  PubMed  Google Scholar 

  104. Sayeed I, Wali B, Stein DG. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci. 2007;25:151–9.

    CAS  PubMed  Google Scholar 

  105. Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y. Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res. 2010;209:119–22.

    Article  CAS  PubMed  Google Scholar 

  106. Coomber B, Gibson CL. Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice. Brain Res. 2010;1361:124–32.

    Article  CAS  PubMed  Google Scholar 

  107. Murphy SJ, Traystman RJ, Hurn PD, Duckles SP. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke. 2000;31:1173–8.

    Article  CAS  PubMed  Google Scholar 

  108. Schumacher M, Denier C, Oudinet JP, Adams D, Guennoun R. Progesterone neuroprotection: the background of clinical trial failure. J Steroid Biochem Mol Biol. 2015.

  109. Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2467–76.

    Article  PubMed  CAS  Google Scholar 

  110. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014;371:2457–66.

  111. Sampei K, Mandir AS, Asano Y, Wong PC, Traystman RJ, Dawson VL, et al. Stroke outcome in double-mutant antioxidant transgenic mice. Stroke. 2000;31:2685–91.

    Article  CAS  PubMed  Google Scholar 

  112. Lang JT, McCullough LD. Pathways to ischemic neuronal cell death: are sex differences relevant? J Transl Med. 2008;6:33.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  113. Renolleau S, Fau S, Charriaut-Marlangue C. Gender-related differences in apoptotic pathways after neonatal cerebral ischemia. Neuroscientist. 2008;14:46–52.

    Article  CAS  PubMed  Google Scholar 

  114. Turtzo LC, McCullough LD. Sex-specific responses to stroke. Future Neurol. 2010;5:47–59.

  115. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M, et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem. 2004;90:1068–75.

    Article  CAS  PubMed  Google Scholar 

  116. Liu F, Lang J, Li J, Benashski SE, Siegel M, Xu Y, et al. Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke. Stroke. 2011;42:1090–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab. 2005;25:502–12.

    Article  CAS  PubMed  Google Scholar 

  118. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD. Sex differences in caspase activation after stroke. Stroke. 2009;40:1842–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Renolleau S, Fau S, Goyenvalle C, Joly LM, Chauvier D, Jacotot E, et al. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem. 2007;100:1062–71.

    Article  CAS  PubMed  Google Scholar 

  120. Alano CC, Kauppinen TM, Valls AV, Swanson RA. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A. 2006;103:9685–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 2007;69:1404–10.

    Article  CAS  PubMed  Google Scholar 

  122. Li J, McCullough LD. Sex differences in minocycline-induced neuroprotection after experimental stroke. J Cereb Blood Flow Metab. 2009;29:670–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Amiri-Nikpour MR, Nazarbaghi S, Hamdi-Holasou M, Rezaei Y. An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect. Acta Neurol Scand. 2015;131:45–50.

    Article  CAS  PubMed  Google Scholar 

  124. Bona E, Hagberg H, Loberg EM, Bagenholm R, Thoresen M. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res. 1998;43:738–45.

    Article  CAS  PubMed  Google Scholar 

  125. Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience. 2006;139:803–11.

    Article  CAS  PubMed  Google Scholar 

  126. Broughton BR, Brait VH, Kim HA, Lee S, Chu HX, Gardiner-Mann CV, et al. Sex-dependent effects of G protein-coupled estrogen receptor activity on outcome after ischemic stroke. Stroke. 2014;45:835–41.

    Article  CAS  PubMed  Google Scholar 

  127. Jia J, Verma S, Nakayama S, Quillinan N, Grafe MR, Hurn PD, et al. Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. J Cereb Blood Flow Metab. 2011;31:2160–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, et al. Strategies and methods for research on sex differences in brain and behavior. Endocrinology. 2005;146:1650–73.

  129. Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 2007;80:84–97.

    Article  CAS  PubMed  Google Scholar 

  130. Ahnstedt H, Mostajeran M, Blixt FW, Warfvinge K, Ansar S, Krause DN, et al. U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats. J Cereb Blood Flow Metab. 2015;35:454–60.

    Article  CAS  PubMed  Google Scholar 

  131. Quillinan N, Deng G, Grewal H, Herson PS. Androgens and stroke: good, bad or indifferent? Exp Neurol. 2014;259:10–5.

    Article  CAS  PubMed  Google Scholar 

  132. Van Kempen TA, Milner TA, Waters EM. Accelerated ovarian failure: a novel, chemically induced animal model of menopause. Brain Res. 2011;1379:176–87.

  133. Friedler B, Crapser J, McCullough L. One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition. Acta Neuropathol. 2015;129:493–509.

    Article  PubMed  Google Scholar 

  134. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509:282–3.

  135. Du L, Bayir H, Lai Y, Zhang X, Kochanek PM, Watkins SC, et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem. 2004;279:38563–70.

    Article  CAS  PubMed  Google Scholar 

  136. Toung TJ, Chen TY, Littleton-Kearney MT, Hurn PD, Murphy SJ. Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab. 2004;24:1160–6.

    Article  CAS  PubMed  Google Scholar 

  137. Dang J, Mitkari B, Kipp M, Beyer C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats.  Brain Behav Immun. 2011;25:715–26.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, University of Vermont, 149 Beaumont Ave., HSRF 416A, Burlington, VT, 05405, USA

    Hilda Ahnstedt & Marilyn J. Cipolla

  2. Department of Neurology, University of Texas Health Science Center, Houston, TX, USA

    Louise D. McCullough

  3. Department of Pharmacology, University of Vermont, Burlington, VT, USA

    Marilyn J. Cipolla

Authors
  1. Hilda Ahnstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louise D. McCullough
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marilyn J. Cipolla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marilyn J. Cipolla.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahnstedt, H., McCullough, L.D. & Cipolla, M.J. The Importance of Considering Sex Differences in Translational Stroke Research. Transl. Stroke Res. 7, 261–273 (2016). https://doi.org/10.1007/s12975-016-0450-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-016-0450-1

Keywords

Search

Navigation